| A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer (NCT05028504) | Sichuan Cancer Hospital and Research Institute | 2022-05-10 |
| Investigation of the Effects of Online Education Application on Gynecological Cancer Patients Receiving Chemotherapy (NCT06574256) | Manisa Celal Bayar University | 2021-12-01 |
| The Effectiveness of Anti-resistance Exercise on Lower Limb Lymphoedema Among Gynecological Cancer (NCT05003973) | National Cheng Kung University | 2021-08-20 |
| A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer (NCT04236362) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-02-27 |
| Laser Therapy Following Radiotherapy for Gynecological Cancer (NCT03714581) | National and Kapodistrian University of Athens | 2018-11-15 |
| Low-Intensity CBT for Gynaecological Cancer Survivors (NCT03553784) | University of Chester | 2018-04-03 |
| Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study (NCT03935698) | Université de Sherbrooke | 2016-09-08 |
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (NCT02906943) | University Health Network, Toronto | 2016-08-01 |
| Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin (NCT02169908) | Fondation Hôpital Saint-Joseph | 2014-05-01 |
| Recovery and Analgesia After Surgery for Gynecological Cancer (NCT02026687) | Lena Nilsson | 2014-03-01 |
| Genomic Investigation of Unusual Responders (NCT03740503) | University Health Network, Toronto | 2013-11-01 |
| Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors (NCT01831089) | PharmaMar | 2013-09-01 |
| Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples (NCT01703585) | University Health Network, Toronto | 2012-10-04 |